Detalhe da pesquisa
1.
Phase II study of figitumumab in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: clinical activity and molecular response (GORTEC 2008-02).
Ann Oncol
; 23(8): 2153-2161, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22234739
2.
Influence of paramagnetic melanin on the MRI contrast in melanoma: a combined high-field (11.7 T) MRI and EPR study.
Contrast Media Mol Imaging
; 9(2): 154-60, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24523060